PMC:7212949 / 47779-47973 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T474","span":{"begin":98,"end":99},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T475","span":{"begin":144,"end":145},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T476","span":{"begin":164,"end":168},"obj":"http://purl.obolibrary.org/obo/CLO_0001414"}],"text":"Clinical features Renal dysfunction ARF (6%) during course of hospitalization Renal dysfunction N/A ARF (17%). 7.2 ± 4.3 days after admission N/A ARF (6.7%) within 5-48 days of onset (median 20)"}

{"project":"LitCovid-sentences","denotations":[{"id":"T484","span":{"begin":0,"end":110},"obj":"Sentence"},{"id":"T485","span":{"begin":111,"end":194},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Clinical features Renal dysfunction ARF (6%) during course of hospitalization Renal dysfunction N/A ARF (17%). 7.2 ± 4.3 days after admission N/A ARF (6.7%) within 5-48 days of onset (median 20)"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T1232","span":{"begin":38,"end":45},"obj":"CHEBI:33695;CHEBI:33695"},{"id":"T1233","span":{"begin":147,"end":155},"obj":"CL:0000233"}],"text":"Clinical features Renal dysfunction ARF (6%) during course of hospitalization Renal dysfunction N/A ARF (17%). 7.2 ± 4.3 days after admission N/A ARF (6.7%) within 5-48 days of onset (median 20)"}